Affiliations 

  • 1 Pharmacogenetics Research Group, Institute for Research in Molecular Medicine, INFORMM, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia
J Clin Pharm Ther, 2006 Apr;31(2):187-91.
PMID: 16635054

Abstract

CYP2C9 is one of the major drug metabolizing enzymes for many drugs including warfarin, NSAIDs and losartan. It is polymorphic in many populations. Data on the distribution of CYP2C9 and the implication of CYP2C9 polymorphism in the Malaysian population is lacking. Our objectives were therefore to investigate the prevalence of CYP2C9 variants among unrelated healthy volunteers of Malays, Chinese and Indians in Malaysia.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.